Colossal
Listed on
$
01234567890.0123456789001234567890
15900.00% VALUATION CHANGE
VALUATION TRAJECTORY
Venture Mandate
Colossal Biosciences is a de-extinction company that aims to resurrect extinct species, starting with the woolly mammoth. By leveraging CRISPR gene-editing technology, they hope to restore ecosystems and combat climate change. This round is to fund the development of artificial wombs and further genetic engineering research.
Valuation
$8.00B
Min. Entry
$1,000
Deal Type
Secondary
Region
Currency
USD
Funding History
| Round | Date | Amount | Valuation |
|---|---|---|---|
Series B | Jan 2023 | $150.0M | $1.0B |
Series A | Mar 2022 | $60.0M | $0.3B |
Seed | Sep 2021 | $15.0M | $0.1B |
Current Offering | Live Now | - | $11.25 / Share |
Market Pulse
Node:
Risk Audit Disclosures
Unprecedented scientific and ethical challenges.
Long and uncertain timelines for success.
High regulatory and public acceptance hurdles.